Alx Oncology Holdings (ALXO) Total Non-Current Liabilities (2019 - 2026)

Alx Oncology Holdings has reported Total Non-Current Liabilities for 8 years, with the latest figure at $23.5 million in Q1 2026.

• Quarterly Total Non-Current Liabilities fell 12.98% year-over-year to $23.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.5 million (down 12.98% YoY) and the FY2025 annual result came in at $29.1 million, up 3.99% from the prior year.
• Total Non-Current Liabilities eased to $23.5 million in Q1 2026 per ALXO's latest filing, from $29.1 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $48.2 million in Q2 2024 and troughed at $15.3 million in Q1 2022.
• A 5-year average of $32.4 million and a median of $29.1 million in 2025 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities jumped 146.58% in 2022, then plunged 46.4% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $37.7 million in 2022, then advanced by 21.02% to $45.6 million in 2023, then plunged by 38.72% to $28.0 million in 2024, then gained by 3.99% to $29.1 million in 2025, then fell by 19.3% to $23.5 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $23.5 million, $29.1 million, and $33.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.